Categories: News

I.P.R. for SMEs in PHARMA – Challenges & Opportunities, 06 August, 2013 Mumbai

Mumbai July 1 2013: We are delighted to inform you that the Associated Chambers of Commerce and Industry of India (ASSOCHAM) is organizing a seminar on “I.P.R. for SMEs in PHARMA” – Challenges & Opportunities on Tuesday, 6th August, 2013 – Mumbai.

We have invited Shri Chaitanya Prasad, IAS, Controller General of Patents, Designs & Trade Marks to kindly grace the occasion as our Guest of Honour. We have also invited Shri K. H. Muniyappa, Hon’ble Minister of State for MSME with Independent Charge to grace the occasion as our esteemed Chief Guest.

 

Healthcare Industry is one of the world’s largest and fastest-growing segments which consume over 10 percent of G.D.P. of most developed nations. Healthcare sector accounts for a fair share of industrial production, exports and has been accepted as the engine of economic growth for promoting equitable development. Healthcare sector has shown admirable innovativeness and adaptability to survive in today’s fiercely competitive environment. India is swiftly budding into a technology-led country, particularly in arena of Healthcare, Pharmaceuticals, & Biotechnology which necessitates an urgent need for capacity building of these sectors to reap benefits out of it.

Objective of the Seminar is to Nurture I.P. culture & implement it in Healthcare / Pharmaceutical sector which will exert positive inducements on Healthcare technological innovation, promote equitable drug pricing, accessible healthcare, commercialization of I.P., protect a firm’s R&D investments, spur incentives for innovation and encourage diffusion of knowledge. This will further impart greater vitality & growth impetus to the Healthcare sector in terms of output, employment and exports thereby instilling a competitive culture based on heightened technology awareness, financial stability, improved production methods and better markets penetration globally.

Considering intricate link between IPR & Healthcare sector along with intensification of globalized trade; implementation & harmonization of patent law worldwide has become an important goal of I.P regime and India need to strike a balance between IPR and Healthcare Sector to overcome the problems faced in affordable and accessible quality healthcare.
The is privileged to be the media partner for the event
http://www.thepharmatimes.in

For more details about this event, please visit:

http://www.assocham.org/events/showevent.php?id=881

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago